MAPrc’s researchers are currently working on a number of projects developing new treatments and diagnostic methods for people experiencing schizophrenia

The following projects are currently recruiting participants.  Please contact us if you wish to receive futher information or to take part in a project. 

Tel: 61 3 9076 6581


Or complete the contact form here.

Transcranial direct current stimulation (tDCS)
tDCS for schizophrenia and schizoaffective disorder uses a very mild electrical current to alter the activity in the areas of the brain thought to be related to these illnesses, as an alternative treatment for symptoms such as low motivation, difficulties with concentration and memory, hearing voices and confused thoughts.We are also conducting investigations with tDCS to learn more about the brain basis of schizophrenia, and to develop new treatments.
For further information click here or contact Susan McQueen on 9076 6595 or email 
Investigation of Ondansetron in Chronic Residual Schizophrenia
A randomised investigation of ondansetron (an anti nausea medication) in schizophrenia participants.
For further information click here or contact recruitment on 9076 6581 or email
Adjunctive SERM Hormone Treatment for Men and Women with Schizophrenia and Schizoaffective Disorder
Men and women who are 18 and over, with schizophrenia or schizoaffective disorder, are invited to take part in a 12-week adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a medication that targets hormone receptors in the brain, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. For further details click here or contact Dr Jasmin Grigg on (03) 9076 6988 or via email
NRAMP - National Register for Antipsychotics in Pregnancy
Observational study of women who are taking or have taken antipsychotic medications during their pregnancy. For further information click here or contact Heather Gilbert on 9076 6591 or email 
EVestG (ElectrovestibuloGraphy)
We are currently trialling a new technique, EVestG (ElectrovestibuloGraphy) which is being investigated as a possible objective method for diagnosing participants with Schizophrenia.  For further information click here or contact MAPrc on 9076 6564 or email
Hearing and language
A study aimed at understanding whether schizophrenia patients have difficulty hearing simple tones and whether this may relate to language difficulties. For further information please click here or contact Chris Groot at
Cognitive remediation and vocational training
A study to examine whether cognitive remediation conducted at the same time as vocational training may assist with patients with schizophrenia returning to work. For further information click here or contact Natalia Contreas at
Brain activity and cognition
A study investigating brain activity and cognition among schizophrenia patients and their relatives. For further information please contact Karyn Richardson on 9076 6564 or email
Genes and brain function

A large collaborative investigation examining how genes and brain function influence the production of language symptoms, including auditory hallucinations and confused speech.  For futher information click here or contact Erica Neill on 9076 5172 or email

 MAPrc Monash Alfred Psychiatry Research Centre, Level 4, 607 St Kilda Road, Melbourne 3004

 © MAPrc 2013. Designed and hosted by Infoxchange Australia